600918:SSEZhongtai Securities Co Ltd Class A Analysis
Data as of 2026-03-17 - not real-time
CN¥6.31
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Zhongtai Securities trades at 6.31 CNY, just above the computed support of 6.14 CNY and below the 20‑day SMA (6.31), 50‑day SMA (6.46) and 200‑day SMA (6.67), signaling a bearish price trend. However, the MACD histogram turned positive and volume is increasing, while the RSI sits near a neutral 47, suggesting limited downside momentum.
Fundamentally, the company posted a striking 59.5% revenue growth and maintains a modest dividend payout (1.04% yield, 11% payout), making the dividend appear sustainable. A DCF‑derived fair value of ~18.3 CNY points to a deep valuation gap, though the trailing PE of 28.7 versus an industry average of 16.5 hints at relative overvaluation. The balance sheet is heavily leveraged (debt‑to‑equity >200%), which tempers the upside despite strong cash holdings.
Fundamentally, the company posted a striking 59.5% revenue growth and maintains a modest dividend payout (1.04% yield, 11% payout), making the dividend appear sustainable. A DCF‑derived fair value of ~18.3 CNY points to a deep valuation gap, though the trailing PE of 28.7 versus an industry average of 16.5 hints at relative overvaluation. The balance sheet is heavily leveraged (debt‑to‑equity >200%), which tempers the upside despite strong cash holdings.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- price hovering just above key support level
- bearish alignment with all major SMAs
- increasing volume but no clear breakout
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- DCF fair value suggests ~3x upside
- robust 59.5% revenue growth
- low dividend payout preserves cash for growth
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- sustained earnings expansion in capital markets
- large cash reserves offset high debt load
- dividend sustainability and potential margin improvement
Key Metrics & Analysis
Financial Health
Revenue Growth59.50%
Profit Margin14.12%
P/E Ratio28.7
ROE4.30%
ROA0.87%
Debt/Equity204.35
P/B Ratio1.1
Op. Cash FlowCN¥4.6B
Industry P/E16.5
Technical Analysis
TrendBearish
RSI47.3
SupportCN¥6.14
ResistanceCN¥6.45
MA 20CN¥6.31
MA 50CN¥6.46
MA 200CN¥6.67
MACDBullish
VolumeIncreasing
Fear & Greed Index79.45
Valuation
Fair ValueCN¥18.31
GradeUndervalued
TypeGrowth
Dividend Yield1.04%
Risk Assessment
Beta0.30
Volatility12.96%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.